Halvorsen Sigrun, Eritsland Jan, Abdelnoor Michael, Holst Hansen Charlotte, Risøe Cecilie, Midtbø Kjell, Bjørnerheim Reidar, Mangschau Arild
Department of Cardiology, Ullevål University Hospital, Oslo, Norway.
Cardiology. 2009;114(2):83-8. doi: 10.1159/000216582. Epub 2009 May 7.
Women with acute myocardial infarction (AMI) previously received less invasive evaluation and experienced higher mortality than men. After improvements in AMI care it is unclear whether gender differences still exist in management and outcome of AMI.
All patients admitted to Ullevål University Hospital for AMI during 2006 and 2007 were included in this cohort study. Predefined data were recorded during the hospital stay, and the survival status of the patients was ascertained on June 30, 2008.
A total of 931 women and 2,174 men were included. No gender differences were observed in treatment delay or age-adjusted odds ratio (OR) of invasive evaluation in ST-elevation myocardial infarction (STEMI). In non-ST-elevation myocardial infarction (NSTEMI), women were less likely than men to undergo coronary angiography (adjusted OR 0.72, 95% CI 0.53-0.99, p = 0.044) and percutaneous coronary intervention (adjusted OR 0.60, 95% CI 0.47-0.76, p = 0.0001). Age-adjusted in-hospital mortality and long-term survival were similar between men and women.
Women with STEMI experienced similar treatment delays and odds of invasive evaluation as men. However, gender differences in invasive evaluation were still observed in NSTEMI patients. No sex differences were observed in age-adjusted early and long-term mortality.
与男性相比,急性心肌梗死(AMI)女性患者以往接受的侵入性评估较少,死亡率较高。在AMI治疗得到改善后,目前尚不清楚在AMI的管理和预后方面性别差异是否仍然存在。
本队列研究纳入了2006年至2007年期间入住于勒沃尔大学医院的所有AMI患者。在住院期间记录预先定义的数据,并于2008年6月30日确定患者的生存状况。
共纳入931名女性和2174名男性。在ST段抬高型心肌梗死(STEMI)的治疗延迟或侵入性评估的年龄校正比值比(OR)方面未观察到性别差异。在非ST段抬高型心肌梗死(NSTEMI)中,女性接受冠状动脉造影的可能性低于男性(校正OR 0.72,95%CI 0.53-0.99,p=0.044)以及接受经皮冠状动脉介入治疗的可能性低于男性(校正OR 0.60,95%CI 0.47-0.76,p=0.0001)。年龄校正后的住院死亡率和长期生存率在男性和女性之间相似。
STEMI女性患者的治疗延迟和侵入性评估几率与男性相似。然而,在NSTEMI患者中仍观察到侵入性评估方面的性别差异。在年龄校正后的早期和长期死亡率方面未观察到性别差异。